157 related articles for article (PubMed ID: 3290700)
1. A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration.
Anderson NE; Budde-Steffen C; Wiley RG; Thurman L; Rosenblum MK; Nadeau SE; Posner JB
Neurology; 1988 Jul; 38(7):1018-26. PubMed ID: 3290700
[TBL] [Abstract][Full Text] [Related]
2. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
Tanaka K; Tanaka M; Igarashi S; Onodera O; Miyatake T; Tsuji S
Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964
[TBL] [Abstract][Full Text] [Related]
3. [Paraneoplastic cerebellar degeneration].
Nakano R; Sato S
Nihon Rinsho; 1994 Nov; 52(11):3000-5. PubMed ID: 7996701
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies in paraneoplastic cerebellar degeneration bind to cytoplasmic antigens of Purkinje cells in humans, rats and mice and are of multiple immunoglobulin classes.
Smith JL; Finley JC; Lennon VA
J Neuroimmunol; 1988 Apr; 18(1):37-48. PubMed ID: 3346369
[TBL] [Abstract][Full Text] [Related]
5. Selective concentration of anti-Purkinje cell antibody in the CSF of two patients with paraneoplastic cerebellar degeneration.
Graus F; Segurado OG; Tolosa E
Acta Neurol Scand; 1988 Sep; 78(3):210-3. PubMed ID: 3227806
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen.
Jaeckle KA; Graus F; Houghton A; Cardon-Cardo C; Nielsen SL; Posner JB
Ann Neurol; 1985 Nov; 18(5):592-600. PubMed ID: 2416270
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic cerebellar degeneration: clinical-immunological correlations.
Anderson NE; Rosenblum MK; Posner JB
Ann Neurol; 1988 Oct; 24(4):559-67. PubMed ID: 3239956
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune paraneoplastic cerebellar degeneration: ultrastructural localization of antibody-binding sites in Purkinje cells.
Rodriguez M; Truh LI; O'Neill BP; Lennon VA
Neurology; 1988 Sep; 38(9):1380-6. PubMed ID: 3045692
[TBL] [Abstract][Full Text] [Related]
9. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration.
Furneaux HM; Rosenblum MK; Dalmau J; Wong E; Woodruff P; Graus F; Posner JB
N Engl J Med; 1990 Jun; 322(26):1844-51. PubMed ID: 2348838
[TBL] [Abstract][Full Text] [Related]
10. Anti-Purkinje cell antibody producing B-cell lines from a patient with paraneoplastic cerebellar degeneration.
Tsukamoto T; Yoshie O; Tada K; Iwasaki Y
Arch Neurol; 1987 Aug; 44(8):833-7. PubMed ID: 3307712
[TBL] [Abstract][Full Text] [Related]
11. Anticerebellar antibodies in serum and cerebrospinal fluid of a patient with oat cell carcinoma of the lung and paraneoplastic cerebellar degeneration.
Greenlee JE; Lipton HL
Ann Neurol; 1986 Jan; 19(1):82-5. PubMed ID: 3004320
[TBL] [Abstract][Full Text] [Related]
12. [Immunobiological approach to spinocerebellar degeneration--anti-Purkinje cell antibodies in paraneoplastic cerebellar degeneration].
Miyatake T
Rinsho Shinkeigaku; 1993 Dec; 33(12):1291-3. PubMed ID: 8174327
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructural localization of anti-Purkinje cell antibody-binding sites in paraneoplastic cerebellar degeneration.
Hida C; Tsukamoto T; Awano H; Yamamoto T
Arch Neurol; 1994 Jun; 51(6):555-8. PubMed ID: 8198465
[TBL] [Abstract][Full Text] [Related]
14. Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume.
Hetzel DJ; Stanhope CR; O'Neill BP; Lennon VA
Mayo Clin Proc; 1990 Dec; 65(12):1558-63. PubMed ID: 2255217
[TBL] [Abstract][Full Text] [Related]
15. Ovarian carcinoma and paraneoplastic cerebellar degeneration.
McLellan R; Currie JL; Royal W; Rosenshein NB
Obstet Gynecol; 1988 Dec; 72(6):922-5. PubMed ID: 3186102
[TBL] [Abstract][Full Text] [Related]
16. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss.
Tanaka M; Tanaka K; Onodera O; Tsuji S
Clin Neurol Neurosurg; 1995 Feb; 97(1):95-100. PubMed ID: 7788981
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune paraneoplastic cerebellar degeneration: immunohistological localization of antibody-binding sites.
Nardelli E; Currò-Dossi B; Rizzuto N; Graus F
Clin Neurol Neurosurg; 1995 Feb; 97(1):89-94. PubMed ID: 7540522
[TBL] [Abstract][Full Text] [Related]
18. [Paraneoplastic cerebellar degeneration].
Chabriat H; Chen QM; Poisson M; Delattre JY
Rev Neurol (Paris); 1994; 150(2):105-14. PubMed ID: 7863150
[TBL] [Abstract][Full Text] [Related]
19. Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model.
Graus F; Illa I; Agusti M; Ribalta T; Cruz-Sanchez F; Juarez C
J Neurol Sci; 1991 Nov; 106(1):82-7. PubMed ID: 1779243
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma.
Greenlee JE; Brashear HR
Ann Neurol; 1983 Dec; 14(6):609-13. PubMed ID: 6360029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
